BACKGROUND: Nonadherence to immunosuppressives, a risk factor for poor posttransplant outcomes, can be assessed by self-report using the Basel Assessment of Adherence to Immunosuppressive Medications Scale (BAASIS). Available in written and interview versions, and previously validated on content, the BAASIS is widely used in research and clinical practice. The aim of this study was to investigate its psychometric properties. METHODS: Using a literature search and our BAASIS database, this meta-analysis identified completed studies in adult transplant recipients whose data were usable to examine the BAASIS' reliability and 3 validity aspects: (1) relationships with other variables (electronic monitoring, other self-report scales, tacrolimus blood-level variability, collateral report, depressive symptoms, psycho-behavioral constructs, and interventions); (2) response processes; and (3) internal structure. Testing used random-effects logistic regressions. RESULTS: Our sample included 12 109 graft recipients from 26 studies. Of these 26, a total of 20 provided individual participant data. Evidence of the BAASIS' stability over time supports its reliability. Validity testing of relationships with other variables showed that BAASIS-assessed nonadherence was significantly associated with the selected variables: electronically monitored nonadherence ( P < 0.03), other self- and collaterally-reported nonadherence ( P < 0.001), higher variability in tacrolimus concentrations ( P = 0.02), higher barriers ( P < 0.001), lower self-efficacy ( P < 0.001), lower intention ( P < 0.001), and higher worries ( P = 0.02). Nonadherence also decreased after regimen change interventions ( P = 0.03). Response process evaluation indicated good readability and slightly higher nonadherence with the written version. Structurally, items on taking and timing shared variability. CONCLUSIONS: The BAASIS shows good validity and reliability as a self-report instrument to assess medication nonadherence in transplantation.

Academic Centre for Nursing and Midwifery Department of Public Health and Primary Care KU Leuven Leuven Belgium

Department of Social and Clinical Pharmacy Faculty of Pharmacy in Hradec Králové Charles University Prague Czech Republic

Institute of Nursing Science Department of Public Health University of Basel Switzerland

Comment In

Transplantation. 2023 Aug 1;107(8):1673-1674. doi: 10.1097/TP.0000000000004575. PubMed

See more in PubMed

De Geest S, Ribaut J, Denhaerynck K, et al. . Adherence management in transplantation: creating impact in real world settings based on state of the art evidence. In: Cukor D, Cohen S, Kimmel PL, eds. Psychosocial Aspects of Chronic Kidney Disease: Exploring the Impact of CKD, Dialysis, and Transplantation on Patients. Academic Press; 2021:409–448.

Neuberger JM, Bechstein WO, Kuypers DR, et al. . Practical recommendations for long-term management of modifiable risks in kidney and liver transplant recipients: a guidance report and clinical checklist by the Consensus on Managing Modifiable Risk in Transplantation (COMMIT) Group. Transplantation. 2017;101:S1–S56. PubMed

Vrijens B, De Geest S, Hughes DA, et al. ; ABC Project Team. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73:691–705. PubMed PMC

De Geest S, Abraham I, Moons P, et al. . Late acute rejection and subclinical noncompliance with cyclosporine therapy in heart transplant recipients. J Heart Lung Transplant. 1998;17:854–863. PubMed

Dang J, King KM, Inzlicht M. Why are self-report and behavioral measures weakly correlated? Trends Cogn Sci. 2020;24:267–269. PubMed PMC

Dobbels F, Berben L, De Geest S, et al. ; Transplant360 Task Force. The psychometric properties and practicability of self-report instruments to identify medication nonadherence in adult transplant patients: a systematic review. Transplantation. 2010;90:205–219. PubMed

Institute of Nursing Science. The Basel Assessment of Adherence to Immunosuppressive Medication Scale (BAASIS©). Available at https://baasis.nursing.unibas.ch/. Accessed March 9, 2022.

Lieb M, Hepp T, Schiffer M, et al. . Accuracy and concordance of measurement methods to assess non-adherence after renal transplantation - a prospective study. BMC Nephrol. 2020;21:114. PubMed PMC

Marsicano Ede O, Fernandes Nda S, Colugnati F, et al. . Transcultural adaptation and initial validation of Brazilian-Portuguese version of the Basel assessment of adherence to immunosuppressive medications scale (BAASIS) in kidney transplants. BMC Nephrol. 2013;14:108. PubMed PMC

Joint Committee on the Standards for Educational and Psychological Testing. The Standards for Educational and Psychological Testing. AERA Publications; 2014.

Schafer-Keller P, Steiger J, Bock A, et al. . Diagnostic accuracy of measurement methods to assess non-adherence to immunosuppressive drugs in kidney transplant recipients. Am J Transplant. 2008;8:616–626. PubMed

Denhaerynck K, Berben L, Dobbels F, et al. ; BRIGHT study team. Multilevel factors are associated with immunosuppressant nonadherence in heart transplant recipients: the international BRIGHT study. Am J Transplant. 2018;18:1447–1460. PubMed PMC

Denhaerynck K, Dobbels F, Cleemput I, et al. . Prevalence, consequences, and determinants of nonadherence in adult renal transplant patients: a literature review. Transpl Int. 2005;18:1121–1133. PubMed

De Geest S, Borgermans L, Gemoets H, et al. . Incidence, determinants, and consequences of subclinical noncompliance with immunosuppressive therapy in renal transplant recipients. Transplantation. 1995;59:340–347. PubMed

De Geest S, Denhaerynck K, Dobbels F. Clinical and economic consequences of nonadherence to immunosuppressive drugs in adult solid organ transplantation. In: Oppenheimer F, ed. Compliance in Solid Organ Transplantation. Permanyer Publications; 2011:63–81.

McGillicuddy JW, Chandler JL, Sox LR, et al. . Exploratory analysis of the impact of an mHealth medication adherence intervention on tacrolimus trough concentration variability: post hoc results of a randomized controlled trial. Ann Pharmacother. 2020;54:1185–1193. PubMed PMC

DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160:2101–2107. PubMed

Fishbein M, Hennessy M, Yzer M, et al. . Can we explain why some people do and some do not act on their intentions? Psychol Health Med. 2003;8:3–18. PubMed

Flesch R. A new readability yardstick. J Appl Psychol. 1948;32:221–233. PubMed

Readability Formulas. Automatic readability checker (our free text readability consensus calculator). Available at https://readabilityformulas.com/free-readability-formula-tests.php. Accessed October 30, 2021.

Sheu CF, Suzuki S. Meta-analysis using linear mixed models. Behav Res Methods Instrum Comput. 2001;33:102–107. PubMed

Kostalova B, Mala-Ladova K, Dusilova-Sulkova S, et al. . Comparison of different methods to assess tacrolimus concentration intra-patient variability as potential marker of medication non-adherence. Front Pharmacol. 2022;13:973564. PubMed PMC

Bessa AB, Felipe CR, Hannun P, et al. . Prospective randomized trial investigating the influence of pharmaceutical care on the intra-individual variability of tacrolimus concentrations early after kidney transplant. Ther Drug Monit. 2016;38:447–455. PubMed

Burkhalter H, Wirz-Justice A, Cajochen C, et al. . Daytime sleepiness in renal transplant recipients is associated with immunosuppressive non-adherence: a cross-sectional, multi-center study. Clin Transplant. 2014;28:58–66. PubMed

De Geest S, Burkhalter H, Berben L, et al. ; Psychosocial Interest Group, Swiss Transplant Cohort Study. The Swiss Transplant Cohort Study’s framework for assessing lifelong psychosocial factors in solid-organ transplants. Prog Transplant. 2013;23:235–246. PubMed

Koller MT, van Delden C, Muller NJ, et al. . Design and methodology of the Swiss Transplant Cohort Study (STCS): a comprehensive prospective nationwide long-term follow-up cohort. Eur J Epidemiol. 2013;28:347–355. PubMed PMC

Dobbels F, De Bleser L, Berben L, et al. . Efficacy of a medication adherence enhancing intervention in transplantation: the MAESTRO-Tx trial. J Heart Lung Transplant. 2017;36:499–508. PubMed

Ducci J, De Simone P, Denhaerynck K, et al. . Clinical consequences of subclinical non adherence to immunosuppression after liver transplantation. Transpl Int. 2013;26:146.

Eisenga MF, Gomes-Neto AW, van Londen M, et al. . Rationale and design of TransplantLines: a prospective cohort study and biobank of solid organ transplant recipients. BMJ Open. 2018;8:e024502. PubMed PMC

Godinas L, Dobbels F, Hulst L, et al. . Once daily tacrolimus conversion in lung transplantation: A prospective study on safety and medication adherence. J Heart Lung Transplant. 2021;40:467–477. PubMed

Gustavsen MT, Midtvedt K, Lonning K, et al. . Evaluation of tools for annual capture of adherence to immunosuppressive medications after renal transplantation - a single-centre open prospective trial. Transpl Int. 2019;32:614–625. PubMed

Liu HX, Teng S, Lin XH, et al. . The application of the necessity-concerns framework in investigating adherence and beliefs about immunosuppressive medication among Chinese liver transplant recipients. Chin Nurs Res. 2017;4:14–17.

Low JK, Manias E, Crawford K, et al. . Improving medication adherence in adult kidney transplantation (IMAKT): a pilot randomised controlled trial. Sci Rep. 2019;9:7734. PubMed PMC

Marsicano EO, Fernandes NS, Colugnati FA, et al. . Multilevel correlates of non-adherence in kidney transplant patients benefitting from full cost coverage for immunosuppressives: a cross-sectional study. PLoS One. 2015;10:e0138869. PubMed PMC

Silva AN, Moratelli L, Tavares PL, et al. . Self-efficacy beliefs, locus of control, religiosity and non-adherence to immunosuppressive medications in kidney transplant patients. Nephrology (Carlton). 2016;21:938–943. PubMed

Sanders-Pinheiro H, Colugnati FAB, Denhaerynck K, et al. ; ADHERE BRAZIL Study Team. Multilevel correlates of immunosuppressive nonadherence in kidney transplant patients: the multicenter ADHERE BRAZIL study. Transplantation. 2021;105:255–266. PubMed

Schmid-Mohler G, Thut MP, Wuthrich RP, et al. . Non-adherence to immunosuppressive medication in renal transplant recipients within the scope of the Integrative Model of Behavioral Prediction: a cross-sectional study. Clin Transplant. 2010;24:213–222. PubMed

Scheel JF, Schieber K, Reber S, et al. . Psychosocial variables associated with immunosuppressive medication non-adherence after renal transplantation. Front Psychiatry. 2018;9:23. PubMed PMC

Scheel J, Reber S, Stoessel L, et al. . Patient-reported non-adherence and immunosuppressant trough levels are associated with rejection after renal transplantation. BMC Nephrol. 2017;18:107. PubMed PMC

Tielen M, Laging M, Beck DK, et al. . Importance of early medication adherence for long-term graft survival: a prospective, single-centre cohort study. Transplantation. 2016;100:S431.

Tielen M, van Exel J, Laging M, et al. . Attitudes to medication after kidney transplantation and their association with medication adherence and graft survival: a 2-year follow-up study. J Transplant. 2014;2014:675301. PubMed PMC

Abedini S, Goransson L, Cockburn E, et al. . Immunosuppression adherence in stable kidney transplant patients converted from immediate- to prolonged-release tacrolimus in clinical practice: a Norwegian study. Transplant Direct. 2018;4:e338. PubMed PMC

Beckebaum S, Iacob S, Sweid D, et al. . Efficacy, safety, and immunosuppressant adherence in stable liver transplant patients converted from a twice-daily tacrolimus-based regimen to once-daily tacrolimus extended-release formulation. Transpl Int. 2011;24:666–675. PubMed

Doesch AO, Mueller S, Akyol C, et al. . Increased adherence eight months after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation. Drug Des Devel Ther. 2013;7:1253–1258. PubMed PMC

Doesch AO, Mueller S, Konstandin M, et al. . Increased adherence after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation: a pre-experimental study. Transplant Proc. 2010;42:4238–4242. PubMed

Fellstrom B, Holmdahl J, Sundvall N, et al. . Adherence of renal transplant recipients to once-daily, prolonged-release and twice-daily, immediate-release tacrolimus-based regimens in a real-life setting in Sweden. Transplant Proc. 2018;50:3275–3282. PubMed

Lehner LJ, Reinke P, Horstrup JH, et al. . Evaluation of adherence and tolerability of prolonged-release tacrolimus (Advagraf) in kidney transplant patients in Germany: a multicenter, noninterventional study. Clin Transplant. 2018;32:1–9. PubMed

Valente G, Rinaldi L, Sgambato M, et al. . Conversion from twice-daily to once-daily tacrolimus in stable liver transplant patients: effectiveness in a real-world setting. Transplant Proc. 2013;45:1273–1275. PubMed

Ioannidis JP, Rosenberg PS, Goedert JJ, et al. ; International Meta-analysis of HIV Host Genetics. Commentary: meta-analysis of individual participants’ data in genetic epidemiology. Am J Epidemiol. 2002;156:204–210. PubMed

Tong A, Oberbauer R, Bellini MI, et al. . Patient-reported outcomes as endpoints in clinical trials of kidney transplantation interventions. Transpl Int. 2022;35:10134. PubMed PMC

Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group : Kasiske BL, Zeier MG, Craig JC, et al. . KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant. 2009;9:S112–S124. PubMed

Hwang YH, Kim H, Min K, et al. . Tacrolimus trough levels in kidney transplant recipients. BMC Nephrol. 2021;22:405. PubMed PMC

Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487–497. PubMed

Vrijens B, Urquhart J. Methods for measuring, enhancing, and accounting for medication adherence in clinical trials. Clin Pharmacol Ther. 2014;95:617–626. PubMed

Leino AD, Abuls KM, Rodgers JKL, et al. . Evaluation of the relationship between medication adherence and tacrolimus coefficient of variation. Prog Transplant. 2022;32:184–189. PubMed

Chisholm MA, Lance CE, Williamson GM, et al. . Development and validation of the immunosuppressant therapy adherence instrument (ITAS). Patient Educ Couns. 2005;59:13–20. PubMed

Voils CI, Hoyle RH, Thorpe CT, et al. . Improving the measurement of self-reported medication nonadherence. J Clin Epidemiol. 2011;64:250–254. PubMed PMC